Identification of a 20-Gene Expression-Based Risk Score as a Predictor of Clinical Outcome in Chronic Lymphocytic Leukemia Patients
Figure 1
GE-based risk score in CLL patients. (a) Clustergram of genes ordered from best to worst prognosis. The level of the probe set signal is displayed from low (deep blue) to high (deep red) expression. (b) CLL patients () were ordered by increasing GE-based risk score.
